Essential data for developing bacteriophage therapeutics

Abstract

The rise of multidrug-resistant organisms is a significant global health threat, projected to cause up to 10 million deaths annually by 2050, surpassing cancer as the leading cause of mortality [1]. Traditional antibiotic development has not kept pace with this threat, necessitating innovative approaches to combat resistant pathogens. Bacteriophage therapy, which leverages viruses to specifically target and destroy bacteria, has emerged as a promising alternative. This letter outlines the key developments in bacteriophage research, the challenges facing its clinical application, and the steps necessary to integrate phage therapy into mainstream medical practice